AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 8193507
Drug: Dicyclomine hydrochloride
RxNorm normalized name: Dicyclomine Hydrochloride
DrugBank: Dicyclomine (DB00804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dicyclomine hydrochloride 3 mg/kg/day
Trial: 8193507
Drug: Pharmacological treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacological treatment (dicyclomine)
Trial: 2454355
Drug: 5 or
RxNorm normalized name: Acys-5 Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 or 10 mg carvedilol once daily for 3 to 7 days, increased to 20 mg daily if BP reduction was insufficient
Trial: 27875516
Drug: 6 months
RxNorm normalized name: leuprolide 45 mg/6 months intramuscular kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 months of trastuzumab treatment
Trial: 8334339
Drug: Baoshen Pill
RxNorm normalized name: Banophen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baoshen Pill (Rheum palmatum extract, RPE)
Trial: 8751804
Drug: Oral Tegafur
RxNorm normalized name: tegafur
DrugBank: Tegafur (DB09256)
FDA approved: no
EMA approved: yes
PMDA approved: no
Description: Oral Tegafur (Group B)
Trial: 19875605
Drug: Autologous umbilical
RxNorm normalized name: Autologous umbilical cord blood
DrugBank: Autologous cord blood (DB17926)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Autologous umbilical cord blood infusion
Trial: 22224244
Drug: Ceraxon (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceraxon (2 g daily for 10 days)
Trial: 8737134
Drug: Sparfloxacin (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sparfloxacin (400 mg loading dose on day 1 followed by 200 mg once daily for pneumonia; 200 mg loading dose on day 1 followed by 100 mg daily for COPD)
Trial: 8737134
Drug: Comparator regimens
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparator regimens (amoxycillin/clavulanic acid 500/125 mg tid, amoxycillin 1000 mg tid, amoxycillin 1000 mg tid plus ofloxacin 200 mg bid, erythromycin 1000 mg bid)
Trial: 1577399
Drug: Etomoxir 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etomoxir 50 mg
Trial: 25261884
Drug: Control condition
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control condition (treatment as usual)
Trial: 11792161
Drug: Chronic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chronic treatment with levetiracetam (individualized, 500-1000 mg twice daily for 8 weeks)
Trial: 28695267
Drug: AAFP 500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AAFP 500 mg with methylprednisolone (4 mg twice daily)
Trial: 28695267
Drug: OAA 1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OAA 1000 mg with prednisone (5 mg twice daily)
Trial: 1621888
Drug: Doxycycline (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxycycline (100 mg/day)
Trial: 7634283
Drug: Antihypertensive treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antihypertensive treatment to achieve blood pressure levels below 85 mmHg
Trial: 2454357
Drug: Carvedilol 50
RxNorm normalized name: carvedilol 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carvedilol 50 mg, administered orally, single and twice daily regimen
Trial: 25792708
Drug: BET 2×1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BET 2×1 mg/day (BET1, n=19)
Trial: 25792708
Drug: BET 2×2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BET 2×2 mg/day (BET2, n=19)
Trial: 7986242
Drug: Effervescent tablet
RxNorm normalized name: Pain Relief Effervescent Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Effervescent tablet
Trial: 15381895
Drug: Methylphenidate (MPH)
DrugBank: Methylphenidate (DB00422)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methylphenidate (MPH) 0.5 mg/kg
Trial: 11931601
Drug: Intact Metadate
RxNorm normalized name: Metadate
DrugBank: Methylphenidate (DB00422)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intact Metadate CD capsules
Trial: 28645284
Drug: Established CVD
RxNorm normalized name: Vibrio cholerae CVD 103-HGR strain live antigen Oral Suspension [Vaxchora]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Established CVD not receiving guideline-recommended treatment prior to the trial
Trial: 21493010
Drug: Clonidine (α2-adrenoceptor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine (α2-adrenoceptor agonist, intravenous infusion)
Trial: 19723122
Drug: Tonabersat 15
RxNorm normalized name: Tonabersat
DrugBank: Tonabersat (DB06578)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tonabersat 15 mg
Trial: 19723122
Drug: Tonabersat 40
RxNorm normalized name: Tonabersat
DrugBank: Tonabersat (DB06578)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tonabersat 40 mg
Trial: 10475318
Drug: Intravenous dextromethorphan
RxNorm normalized name: Dextromethorphan
DrugBank: Dextromethorphan (DB00514)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous dextromethorphan 5 mg/kg before anesthetic induction (Pre group)
Trial: 2220663
Drug: Surgery and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgery and radiation therapy
Trial: 28074475
Drug: LPS injection
RxNorm normalized name: LP-20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LPS injection (0.4 or 0.8 ng/kg)
Trial: 24941951
Drug: Fiber-enriched orange
RxNorm normalized name: Orange
DrugBank: Orange (DB10549)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fiber-enriched orange juice (400 mL for 21 days)
Trial: 24941951
Drug: Placebo orange
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo orange juice (400 mL for 21 days)
Trial: 21663648
Drug: 45 g
RxNorm normalized name: SODIUM CHLORIDE 0.045 g in 5 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 45 g milk fat/d from test butter and cheese with 0.24 wt% phytanic acid
Trial: 30078537
Drug: Basic saline
RxNorm normalized name: Basic Fuchsin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basic saline solution (Control)
Trial: 24356636
Drug: Conventional tri-weekly
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional tri-weekly paclitaxel and carboplatin (c-TC)
Trial: 22629129
Drug: Intravenous anesthesia
RxNorm normalized name: Gelato Anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous anesthesia (Anesthesia Group, AG)
Trial: 20080382
Drug: Paracetamol 500
RxNorm normalized name: Paracetamol 500 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracetamol 500 mg, Caffeine 50 mg, Opium 25 mg
Trial: 20080382
Drug: Paracetamol 500
RxNorm normalized name: Paracetamol 500 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracetamol 500 mg, Caffeine 50 mg, Opium 50 mg
Trial: 21640574
Drug: Tramadol 100
RxNorm normalized name: tramadol 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol 100 mg
Trial: 15378234
Drug: Permacol injection
RxNorm normalized name: lidocaine hydrochloride Topical Spray [Dermacool]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Permacol injection
Trial: 19013613
Drug: Macroplastique injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Macroplastique injection
Trial: 10710824
Drug: New microemulsion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New microemulsion formulation of cyclosporine
Trial: 1838749
Drug: OPC‐7251 1%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OPC‐7251 1% cream
Trial: 22624993
Drug: Cream base
RxNorm normalized name: Cream Base
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cream base
Trial: 7015173
Drug: Low-dose heparin
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose heparin (LDH) injected subcutaneously in the contralateral thigh
Trial: 7015173
Drug: Low-dose heparin
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose heparin (LDH) injected subcutaneously in the contralateral abdominal skin-fold
Trial: 28217880
Drug: Cognitive remediation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive remediation therapy (CRT) and treatment as usual (TAU)
Trial: 7883848
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg iodine
Trial: 7883848
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg iodine
Trial: 7883848
Drug: 800 mg
RxNorm normalized name: bran 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 800 mg iodine
Trial: 1453217
Drug: Lupin protein
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lupin protein at 0.8 g/(kg.d)
Trial: 1453217
Drug: Lupin protein
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lupin protein at 0.6 g/(kg.d)
Trial: 1453217
Drug: Lupin protein
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lupin protein at 0.4 g/(kg.d)
Trial: 1453217
Drug: Egg protein
RxNorm normalized name: Egg protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Egg protein at 0.6 g/(kg.d)
Trial: 1453217
Drug: Egg protein
RxNorm normalized name: Egg protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Egg protein at 0.45 g/(kg.d)
Trial: 6366810
Drug: Co-trimoxazole (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Co-trimoxazole (400 mg sulphamethoxazole plus 80 mg trimethoprim)
Trial: 26912543
Drug: Tolvaptan (45/15,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tolvaptan (45/15, 60/30, or 90/30 mg daily as tolerated)
Trial: 14617323
Drug: Continuous IV
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous IV infusion of calcium-gluconate at a dose of 1.8 mmol calcium per hour
Trial: 14617323
Drug: Continuous IV
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous IV infusion of calcium-gluconate
Trial: 29080061
Drug: No chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No chemotherapy
Trial: 3114302
Drug: Bromocriptine (BCT;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bromocriptine (BCT; 3.75 mg/day; n = 14)
Trial: 23019944
Drug: Routine treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine treatment (RTT)
Trial: 18055726
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C (1,000 mg) and Vitamin E (400 International Units)
Trial: 16126331
Drug: InCare Advance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: InCare Advance Plus (gel-lubricated uncoated catheter)
Trial: 19318455
Drug: Transdermal estrogen
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal estrogen (TD E2)
Trial: 11599198
Drug: Spironolactone with
RxNorm normalized name: Spironolactone
DrugBank: Spironolactone (DB00421)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Spironolactone with ACE-inhibitor
Trial: 11599198
Drug: ACE-inhibitor
RxNorm normalized name: C1-inhibiting factor
DrugBank: Human C1-esterase inhibitor (DB06404)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACE-inhibitor
Trial: 11599198
Drug: Spironolactone and
RxNorm normalized name: Spironolactone and torsemide only product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spironolactone and ACE-inhibitor
Trial: 9394235
Drug: Faropenem (FRPM)
RxNorm normalized name: Meropenem
DrugBank: Faropenem (DB12190)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Faropenem (FRPM) in combination with Enteronon-R (E-group)
Trial: 8424507
Drug: Epidural morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural morphine (EM) 100 micrograms/kg
Trial: 8874561
Drug: Epidural morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural morphine (EM)
Trial: 8424507
Drug: Intravenous morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous morphine (IM)
Trial: 5072238
Drug: +/- propranolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: +/- propranolol (120 mg)
Trial: 22956408
Drug: intravenous immunoglobulin
RxNorm normalized name: Intravenous immunoglobulin (IVIg)
DrugBank: Human immunoglobulin G (DB00028)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: intravenous immunoglobulin (IVIG, 0.4 g/kg/day for 5 days)
Trial: 18704101
Drug: Active TMS
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active TMS (transcranial magnetic stimulation) administered to the left dorsolateral prefrontal cortex at 10 pulses per second, 120% of motor threshold, for a total of 3000 pulses per day
Trial: 24081023
Drug: Raloxifene (RLX)
DrugBank: Raloxifene (DB00481)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Raloxifene (RLX) 60 mg/day
Trial: 15295352
Drug: Slow-dose escalation
RxNorm normalized name: Slow-Fe
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Slow-dose escalation (SDE)
Trial: 11330366
Drug: Regional antimicrobial
RxNorm normalized name: GAUZE,ANTIMICROBIAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regional antimicrobial prophylaxis (teicoplanin 400 mg)
Trial: 11330366
Drug: Perioperative antibiotic
RxNorm normalized name: ENSURE SURGERY PERIOPERATIVE KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perioperative antibiotic prophylaxis (teicoplanin 800 mg)
Trial: 26622463
Drug: 5% 5-ALA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% 5-ALA for 1.5 h followed by three 20-min doses of infrared radiation once a week for 3 weeks
Trial: 23463180
Drug: Telephone-assisted parent-administered
RxNorm normalized name: C.I. direct red 28 parent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telephone-assisted parent-administered behavioural intervention (bibliotherapy)
Trial: 18000162
Drug: Atorvastatin (n
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin (n = 19)
Trial: 11393383
Drug: Spirapril 6
RxNorm normalized name: spirapril 6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spirapril 6 mg daily
Trial: 2859256
Drug: Alprazolam (1.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alprazolam (1.2 mg/day)
Trial: 27429618
Drug: Conventional periodontal
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conventional periodontal therapy
Trial: 30807279
Drug: .00 g/dl
FDA approved: no
EMA approved: no
PMDA approved: no
Description: .00 g/dl alcohol dose
Trial: 9426022
Drug: Captopril 25
RxNorm normalized name: captopril 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril 25 mg three times daily without NTG
Trial: 29985079
Drug: One-step approach
RxNorm normalized name: PostDay One-Step
DrugBank: Levonorgestrel (DB00367)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: One-step approach (75-g glucose load, fasting, 1h, and 2h measurements)
Trial: 29985079
Drug: Two-step approach
RxNorm normalized name: zinc oxide
DrugBank: Zinc oxide (DB09321)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Two-step approach (50-g glucose load followed by 100-g glucose load if necessary)
Trial: 28028994
Drug: Genexol-PM (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Genexol-PM (300 mg/m², once every 3 weeks) + carboplatin (AUC 5)
Trial: 28028994
Drug: Genexol-PM (220
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Genexol-PM (220 mg/m², once every 3 weeks) + carboplatin (AUC 5)
Trial: 26352813
Drug: Sebelipase alfa
RxNorm normalized name: Sebelipase alfa
DrugBank: Sebelipase alfa (DB11563)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Sebelipase alfa (1 mg/kg, intravenously, every other week)
Trial: 23345000
Drug: Oral CP-4126
RxNorm normalized name: CP
DrugBank: Captopril (DB01197)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral CP-4126 (100-3000 mg/day)
Trial: 23345000
Drug: Oral CP-4126
RxNorm normalized name: CP
DrugBank: Captopril (DB01197)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral CP-4126
Trial: 19882058
Drug: Ropivacaine 7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine 7.5 mg plus 25 ug of fentanyl
Trial: 16758644
Drug: Intracoronary injection
RxNorm normalized name: HELIUM 992 mL in 1 L INTRACORONARY GAS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracoronary injection of bone marrow mononuclear cells
Trial: 7661066
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no antiarrhythmic therapy)
Trial: 19272057
Drug: Quinidine therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinidine therapy
Trial: 7001961
Drug: Flunisolide (inhaled
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flunisolide (inhaled steroid)
Trial: 31715161
Drug: Broad-spectrum combination
RxNorm normalized name: Sentinel Spectrum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Broad-spectrum combination empiric antibiotics
Trial: 21044166
Drug: Implant-cantilever group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Implant-cantilever group (1 implant with cantilever)
Trial: 17531578
Drug: Candesartan 8
RxNorm normalized name: candesartan 8 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Candesartan 8 mg/day for 3 to 6 weeks before and 16 mg/day for 6 months after electrical cardioversion
Trial: 15768732
Drug: Probiotics (1.2g/d)
RxNorm normalized name: Rezyst Probiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotics (1.2g/d) and soluble fiber (11g/d) with L-Glutamine (30g/d) if diarrhea persisted at week 4
Trial: 8446846
Drug: Omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 20 mg
Trial: 2737271
Drug: Formoterol (12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Formoterol (12 micrograms twice daily)
Trial: 2737271
Drug: Salbutamol (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salbutamol (200 micrograms twice daily)
Trial: 27939076
Drug: Simtuzumab (125
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simtuzumab (125 mg/mL, subcutaneously once a week)
Trial: 21303934
Drug: Problem-solving therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Problem-solving therapy (PST) delivered via videophones
Trial: 12622106
Drug: Target-controlled infusion
RxNorm normalized name: Diphtheria toxin-il-3 fusion protein targeting IL-3 receptor
DrugBank: Tagraxofusp (DB14731)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Target-controlled infusion of propofol combined with midazolam
Trial: 8983891
Drug: Adjuvant chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant chemotherapy with FEM (specifically for histologic grade III tumors)
Trial: 6751510
Drug: gentamicin-betamethasone ointment
RxNorm normalized name: betamethasone / gentamicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: gentamicin-betamethasone ointment
Trial: 23397347
Drug: Oral vitamin
RxNorm normalized name: vitamin A Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral vitamin A (7500 μg) once a week
Trial: 19809026
Drug: Intravenous infusions
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous infusions of Fe(III)-hydroxide sucrose (400 mg) after venesection
Trial: 19809026
Drug: Venesection of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Venesection of 2 L of blood (iron depletion)
Trial: 9503532
Drug: Molsidomine (M)
RxNorm normalized name: molsidomine
DrugBank: Molsidomine (DB09282)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Molsidomine (M) administered for 3 weeks, 4 times a day
Trial: 30115593
Drug: Temozolomide (150-200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Temozolomide (150-200 mg/m2, orally) monotherapy on days 1-5 every 4 weeks for a maximum of 12 cycles
Trial: 30115593
Drug: Bevacizumab (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bevacizumab (10 mg/kg, intravenously) in combination with temozolomide (150-200 mg/m2, orally)
Trial: 30115593
Drug: Temozolomide monotherapy
RxNorm normalized name: Temozolomide
DrugBank: Temozolomide (DB00853)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Temozolomide monotherapy
Trial: 30115593
Drug: Bevacizumab and
RxNorm normalized name: Bevacizumab
DrugBank: Bevacizumab (DB00112)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Bevacizumab and temozolomide combination
Trial: 27695978
Drug: Red spinach
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Red spinach extract (RSE) 1000 mg dose; 90 mg nitrate
Trial: 20055772
Drug: Antiparkinson drug
RxNorm normalized name: OTHER ANTIPARKINSON DRUGS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiparkinson drug treatment
Trial: 19057272
Drug: Celecoxib 400
RxNorm normalized name: celecoxib 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celecoxib 400 mg orally twice daily + Docetaxel 75 mg/m2 intravenously on a 21-day cycle
Trial: 12207638
Drug: Rifabutin (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rifabutin (300 mg once daily) alone
Trial: 11399369
Drug: iodixanol 270
RxNorm normalized name: IODIXANOL 270mgI/ml INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: iodixanol 270 mg I/ml
Trial: 8944373
Drug: Lansoprazole 30
RxNorm normalized name: lansoprazole 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lansoprazole 30 mg daily (LAN30)
Trial: 2011924
Drug: Standard-dose alpha-IFN
RxNorm normalized name: IFN .ALPHA.-1B
DrugBank: Interferon alfa-1b (DB18522)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-dose alpha-IFN (3 MU/day i.m. for 6 months, then 3 MU three times/week for a further 6 months)
Trial: 29797695
Drug: Theobromine (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Theobromine (500 mg d‐1 for 4 weeks)
Trial: 29797695
Drug: Placebo (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (500 mg d‐1 for 4 weeks)
Trial: 10793015
Drug: Ondansetron (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ondansetron (8 mg) three times daily for 2 weeks